Dusseldorf - Delayed Quote • EUR
Xenon Pharmaceuticals Inc (XP0.DU)
As of 7:30 PM GMT+2. Market Open.
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
--
--
9,434.00
18,437.00
32,166.00
Gross Profit
3,500.00
--
--
--
--
Operating Expense
214,054.00
214,054.00
138,577.00
97,430.00
63,467.00
Operating Income
-214,054.00
-214,054.00
-129,143.00
-78,993.00
-31,301.00
Net Non Operating Interest Income Expense
27,620.00
27,620.00
8,713.00
466.00
1,795.00
Other Income Expense
3,749.00
3,749.00
-4,825.00
-361.00
412.00
Pretax Income
-182,685.00
-182,685.00
-125,255.00
-78,888.00
-29,094.00
Tax Provision
-292.00
-292.00
118.00
-6.00
-257.00
Net Income Common Stockholders
-182,393.00
-182,393.00
-124,936.00
-77,087.00
-28,013.00
Diluted NI Available to Com Stockholders
-182,393.00
-182,393.00
-124,936.00
-77,087.00
-28,013.00
Basic EPS
-2.73
-2.73
-2.06
-1.77
-0.81
Diluted EPS
-2.73
-2.73
-2.06
-1.77
-0.81
Basic Average Shares
66,889.01
66,889.01
60,542.14
43,627.45
34,542.21
Diluted Average Shares
66,889.01
66,889.01
60,542.14
43,627.45
34,542.21
Total Operating Income as Reported
-214,054.00
-214,054.00
-129,143.00
-78,993.00
-31,301.00
Total Expenses
214,054.00
214,054.00
138,577.00
97,430.00
63,467.00
Net Income from Continuing & Discontinued Operation
-182,393.00
-182,393.00
-125,373.00
-78,882.00
-28,837.00
Normalized Income
-186,136.01
-186,136.01
-121,812.63
-78,521.03
-29,245.36
Interest Income
27,620.00
27,620.00
8,713.00
466.00
2,279.00
Interest Expense
--
--
--
--
484.00
Net Interest Income
27,620.00
27,620.00
8,713.00
466.00
1,795.00
EBIT
-214,054.00
-214,054.00
-129,143.00
-78,993.00
-28,610.00
EBITDA
-210,513.00
-210,513.00
-127,519.00
-78,087.00
-27,966.00
Reconciled Depreciation
3,541.00
3,541.00
1,624.00
906.00
644.00
Net Income from Continuing Operation Net Minority Interest
-182,393.00
-182,393.00
-125,373.00
-78,882.00
-28,837.00
Total Unusual Items Excluding Goodwill
3,749.00
3,749.00
-4,825.00
-361.00
412.00
Total Unusual Items
3,749.00
3,749.00
-4,825.00
-361.00
412.00
Normalized EBITDA
-214,262.00
-214,262.00
-122,694.00
-77,726.00
-28,378.00
Tax Rate for Calcs
0.00
0.00
0.00
0.00
0.00
Tax Effect of Unusual Items
5.99
5.99
-1,264.63
-0.03
3.64
12/31/2020 - 10/21/2021
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade